These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3936186)

  • 1. The demand for prescription drugs as a function of cost-sharing.
    Leibowitz A; Manning WG; Newhouse JP
    Soc Sci Med; 1985; 21(10):1063-9. PubMed ID: 3936186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.
    Alan S; Crossley TF; Grootendorst P; Veall MR
    J Health Econ; 2002 Sep; 21(5):805-26. PubMed ID: 12349883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.
    Bai G; Sen AP; Anderson GF
    Ann Intern Med; 2018 Mar; 168(6):436-437. PubMed ID: 29435565
    [No Abstract]   [Full Text] [Related]  

  • 6. Substitution between prescribed and over-the-counter medications.
    Leibowitz A
    Med Care; 1989 Jan; 27(1):85-94. PubMed ID: 2911221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of medicine.
    Silk AD
    West J Med; 1990 Jan; 152(1):75-6. PubMed ID: 2309481
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.
    Gilman BH; Kautter J
    Health Serv Res; 2008 Apr; 43(2):478-95. PubMed ID: 18370964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Consumer Cost-Sharing for Health Plans Sold in the ACA's Insurance Marketplaces, 2015 to 2016.
    Gabel J; Green M; Call A; Whitmore H; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 May; 11():1-14. PubMed ID: 27214926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prescription-drug problem.
    Steinbrook R
    N Engl J Med; 2002 Mar; 346(11):790. PubMed ID: 11893789
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of brand drug discount cards on private insurer, government and patient expenditures.
    Law MR; Chan FKI; Harrison M; Worthington HC
    CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Changes or Big Ones? The Case of Limits on Prescription Drug Copayments in California.
    Pyenson B; Dieguez G; Simon K; Bochner A
    Manag Care; 2018 Jul; 27(7):27-29. PubMed ID: 29989898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiatives to control drug costs associated with an independent physician association.
    Abourjaily P; Kross J; Gouveia WA
    Am J Health Syst Pharm; 2003 Feb; 60(3):269-72. PubMed ID: 12613237
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tier 4 drugs and the fraying of the social compact.
    Lee TH; Emanuel EJ
    N Engl J Med; 2008 Jul; 359(4):333-5. PubMed ID: 18650510
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
    Fairman KA; Motheral BR; Henderson RR
    Clin Ther; 2003 Dec; 25(12):3147-61; discussion 3144-6. PubMed ID: 14749153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.